Ozone therapy in patients with Retinitis Pigmentosa

Ozone: Science and Engineering

Volumn 25, Issue 3, 2003, Pages 223-232

  Copello, Mirtha ^a   Eguía, Frank ^b   Menéndez, Silvia ^c   Menéndez, Niusdalys ^a  

^a Hospital Docente Dr Salvador Allende   (Cuba)

^b Cuban Ophthalmology Institute Ramon Pando Ferrer   (Cuba)

^c Ozone Research Center Havana   (Cuba)

Author keywords

Lipid Peroxidation; Medical Applications; Ozone; Ozone Therapy; Retinitis Pigmentosa

Indexed keywords

OPHTHALMOLOGY; OZONE;

OZONE THERAPY;

PATIENT TREATMENT;

EID: 0042522390     PISSN: 01919512     EISSN: None     Source Type: Journal    
DOI: 10.1080/01919510390481540     Document Type: Article

References (61)

1. Heckenlively, J.R., Retinitis Pigmentosa. (Philadelphia. USA: JB Lippincott: 1988).
2. Farrar, G.J., P.F. Kenna and P. Humphries, "On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention", EMBO J. 21(5):857-864 (2002).
3. Berson, E.L., "Retinitis Pigmentosa and allied diseases" in: Albert, D.M., Jacobietz, F.A. eds., Principles and Practice of Ophthalmology: Clinical Practice. Vol. 2 (Philadelphia. USA: WB Saunders, 1994). p.1214-1237.
4. Berson, E.L., "Retinitis Pigmentosa. The Friedenwald Lecture", IOVS 34:1659-1676 (1993).
5. Peláez, O., Retinosis Pigmentaria. Experencia Cubano (La Habana, Cuba: Ed. Cientifico-Técnica, 1995).
6. Verhoeff, F.H., "Microscopic observations in case of Retinitis Pigmentosa", Arch. Opthahnol. 5:392-407 (1931).
7. Ohguro, H., T. Maeda, S. Yanagihashi, Y. Miyakawa, I. Maruyama and M. Nakazawa, "Molecular pathology of retinitis pigmentosa", Nippon Ganka Gakkai Zasshi 106(8):461-473 (2002).
8. Radtke, N.D., M.J. Seiler, R.B. Aramant, H.M. Petry and D.J. Pidwell, "Transplantation of intact sheets of fetal neural retina with its retinal pigment epithelium in retinitis pigmentosa patients", Am. J. Ophthalmol. 133(4):544-550 (2002).
9. Galimova, V.U., "Time course of visual functions in patients with pigmentary retinal degeneration after surgical treatment with biomaterial "Alloplant"", Vestn. Oftalmol. 117(3):20-23 (2001).
10. Zrenner, E. and K. Ruther, "Administration of vitamin A derivatives in hereditary retinal degeneration. Status of recommendations", Ophthalmologe 98(6):526-528 (2001).
11. Sahel, J.A., S. Mohand-Said, T. Leveillard, D. Hicks, S. Picaud and H. Dreyfus, "Rod-cone interdependence: implications for therapy of photoreceptor cell diseases". Prog. Brain Res. 131:649-661 (2001).
12. Grant, C.A., E.L. Berson, "Treatable forms of retinitis pigmentosa associated with systemic neurological disorders", Int. Ophthalmol. Clin. 41(1):103-110 (2001).
13. Berson, E.L., "Nutrition and retinal degenerations", Int. Ophthalmol. Clin. 40(4):93-111 (2000).
14. Sibulesky, L., K.C. Hayes, A. Pronczuk, C. Weigel-DiFranco, B. Rosner and E. L. Berson, "Safety of <7500 RE (<25000 lU) vitamin A daily in adults with retinitis pigmentosa"., Am. J. Clin. Nut. 69(4):656-663 (1999).
15. Coffey, P.J., S. Girman, S.M. Wang, L. Hetherington, D.J. Keegan, P. Adamson, J. Greenwood and R.D. Lund, "Long-term preservation of cortically dependent visual function in RCS rats by transplantation", Nat. Neurosci. 5(1):53-56 (2002).
16. Flinn, E.D., "Ceramic photocell implants could restore sight", Aerosp. Am. 40(4):18-19 (2002).
17. Liang, F.Q., N.S. Dejneka, D.R. Cohen, N.V. Krasnoperova, J. Lem, A.M. Maguire, L. Dudus, K.J. Fisher and J. Bennett, "AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse", Mol. Ther. 3(2):241-248 (2001).
18. Liang, F.Q., T.S. Aleman, N.S. Dejneka, L. Dudus, K.J. Fisher, A.M. Maguire, S.G. Jacobson and J. Bennett, "Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa", Mol. Ther. 4(5):461-72 (2001).
19. Sarra, G.M., C. Stephens, M. de Alwis, J.W. Bainbridge, A.J. Smith, A.J. Thrasher and R.R. Ali, "Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina", Hum. Mol. Genet. 10(21):2353-2361 (2001).
20. McDonald, H.R., "Diagnostic and therapeutic challenges", Retina 21(5):521-525 (2001).
21. Vollrath, D., W. Feng, J.L. Duncan, D. Yasumura, P.M. D'Cruz, A. Chappelow, M.T. Matthes, M.A. Kay and M.M. LaVail, "Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk", Proc. Natl. Acad. Sci. USA 23;98(22):12584-12589 (2001).
22. Dejneka, N.S. and J. Bennett, "Gene therapy and retinitis pigmentosa: advances and future challenges", Bioessays 23(7):662-668 (2001).
23. Bennett, J., "Gene therapy for retinitis pigmentosa", Curr. Opin. Mol. Ther. 2(4):420-425 (2000).
24. Triana, I., S. Menéndez, O. Peláez and M. Copello, "La ozonoterapia en el campo de la Oftalmologia", Rev. Cubana de Oftalmología 2 (3):168-172 (1990).
25. th Ozone World Congress Vol. 3 International Ozone Association Ed. (Lille, France: Insta Print S.A. Tours, 1995), p. 99-106.
26. Riva Sanseverino, E., R.A. Meduri and A. Pizzini, "Effects of oxygen-ozone therapy on age-related degenerative retinal maculopathy", Panminerva Med. 32:77-84 (1990).
27. Menéndez, S., O. Peláez, M. Gómez and M. Copello, "Aplicación de la ozonoterapia en la retinosis pigmentaria", Rev. Cubana de Oftalmología, 3(1):35-39, (1990).
28. rd English edition (Iffezheim, Germany: ODREI-Publishers, 1999), p.95-119.
29. Bocci, V., "Ozone as a bioregulalor. Pharmacology and toxicology of ozonetherapy today". J. Biol. Reg. Homeostatic Agents., 10(2/3):1-53 (1997).
30. Barber, E., S. Menéndez, O.S. León, M.O. Barber, N. Merino, J.L. Calunga, E. Cruz and V. Bocci, "Prevention of renal injury after reduction of ozone tolerance in rats submitted to warm ischemia", Mediators of Inflammation 8:37-41 (1999).
31. Hernández, F., S. Menéndez and R. Wong, "Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy", Free Rad. Biol. Med. 19:115-119 (1995).
32. León, O.S., S. Menéndez, N. Merino, R. Castillo, S. Sam, L. Pérez, E. Cruz and V. Bocci, "Ozone oxidative preconditioning: a protection against cellular damage by free radicals", Mediators of Inflammation 7:289-294 (1998).
33. Peralta, C., O.S. Leon, C. Xaus, N. Prats, E.C. Jalil, E.S. Planell, P. Puig-Parellada, E. Gelpí, J. Roselló-Catafau, "Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance". Free Rad. Res. 31:191-196 (1999).
34. Candelario-Jalil, E., S. Mohammed-Al-Dalain, O.S. León, S. Menéndez, G. Pérez-Davidson, N. Merino, S. Sam and H.H. Ajamieh, "Oxidative preconditioning affords protection against carbon tetrachloride-induced glycogen depletion and oxidative stress in rats". J. Appl. Toxicol. 21:297-301 (2001).
35. Ajamieh, H., N. Merino, E. Candelario-Jalil, S. Menéndez, G. Martínez, L. Re, A. Giutiani and O.S. León, "Similar protecnve effect of ischemic and ozone oxidative preconditionings in liver ischaemia/reperfusion injury". Pharmaceutical Research. 45(4):333-339 (2002).
36. Al-Dalain, S.M., G. Martínez, E. Candelario-Jalil, S. Menéndez, L. Re, A. Giuliani and O.S. León, "Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats" Pharmaceutical Research. 44(5):391-396 (2001).
37. Gerster, H., "Review: antioxidant protection on ageing macula", Age Ageing 20:60-69 (1991).
38. Katz, M.L., W.G. Robinson and E.A. Dratz, "Potencial role of autoxidation in age changes in the retina and retinal pigment epithelium of the eye", in. Armstrong, D., Sohol, R.S., Cutler, R.G., Slater, T.F. eds., Free Radicals in Molecular Biology, Aging and Disease. (New York, USA: Raven Press, 1984), p.163-180.
39. Baumgartner, W.A., "Etiology, pathogenesis, and experimental treatment of retinitis pigmentosa", Med. Hypotheses 54(5):814-824 (2000).
40. Liang F.Q., T.S. Aleman, Y. Zaixin, A.V. Cideciyan, S.G. Jacobson and J. Bennett, "Melatonin delays photoreceptor degeneration in the rds/rds mouse", Neuroreport 17:12(5):1011-1014 (2001).
41. Carmody, R.J. and T.G. Cotter, "Oxidative stress induces caspase-independent retinal apoptosis in vitro", Cell Death Differ. 7(3):282-291 (2000).
42. Carmody, R.J., A.J. McGowan and T.G. Cotter, "Reactive oxygen species as mediators of photoreceptor apoptosis in vitro", Exp. Cell Res. 248(2):520-530 (1999).
43. Garland, D.L., "Ascorbic acid and the eye", Am. J. Clin. Nutr. 54:11988-12028 (1991).
44. Knight, J.A., "Diseases related to oxygen-derived free radicals", Ann. Clin. Lab. Sci. 25(2): 111-121 (1995).
45. Young, R.W., "Solar radiation and age-related macular degeneration", Surv. Opthalmol. 32:252-269 (1988).
46. Jaques, P.F., L.T. Chylack, Jr., "Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention", Am. J. Clin. Nutr. 53:352S-355S (1991).
47. Szlyk, J.P., W. Seiple, G.A. Fishman, K.R. Alexander, S. Grover and C.L. Mahler, "Perceived and actual performance of daily tasks: relationship to visual function tests in individuals with retinitis pigmentosa", Ophthalmology 108(1):65-75 (2001).
48. Ross, D. et al., "Variability of visual field measurements in normal and patients with RetinitisPigmentosa", Arch. Ophthalmol., 102:1004-1010 (1984).
49. Humphries, P. et al., "On the molecular genetics of Retinitis Pigmentosa", Science 256: 804-808 (1992).
50. Berson, E. L. et al., "Natural course of Retinitis Pigmentosa over a three-year interval", AJO 99(3):240-251 (1985).
51. Grover, S., G.A. Fishman and R.J. Anderson, "Rate of visual field in Retinitis Pigmentosa", Ophthalmology 104:460-465 (1997).
52. Berson, E.L., J.F.C. Remulla, B. Rosner, M.A. Sandberg and C. Weigel-Franco, "Evaluation of patients with retinitis pigmentosa receiving electric stimulation, ozonated blood and ocular surgery in Cuba", Arch. Opthalmol. 114:560-563 (1996).
53. Welebwe, R.G., "The Cuban experiment: false hope for a cure for retinitis pigmentosa", Arch. Opthalmol. 114:606-607 (1996).
54. Marmer, R. and S. Parks, "Ozone treatment in retinitis pigmentosa: effect on color perception and blood gasses", Ann. Opthalmol. 30(3): 161-163 (1998).
55. Marmer, R. and S. Parks, "Ozone treatment in retinitis pigmentosa: effect on photo stress and contrast sensitivity", Ann. Opthalmol. 30(3):164-166 (1998).
56. Marshall, J. and J. Heckenlively, Pathological findings and putative mechanisms in Retinitis Pigmentosa (Philadelphia, USA: JB Lippincott, 1988), p. 37-63.
57. Lu, Z., "Histopatology of bone-spicule pigmentation in Retinitis Pigmentosa", Ophthalmology 162:805-816 (1995).
58. Grunnwald, J.E., "Retinal Hemodynamics in Retinitis Pigmentosa". AJO 122 (4):502-508 (1996).
59. Winstean, G.W., A.E. Maumenee and L. Hyvarinen, "On the pathogenesis of the Pigmentary Retinitis", Ophthalmology 62:82-97 (1971).
60. Bocci, V., "Ozone: a mixed blessing", Forsch. Komplementärmed. 3:25-33 (1996).
61. Fulton, W., "How shall research in the treatment of Retinitis Pigmentosa proceed?". Arch. Ophthalmol. 111(6):754-756 (1993).